Thorium-228 is the parent radionuclide of Lead-212 (Pb-212), an isotope increasingly used in the development of targeted radiotherapeutics. Using a proprietary Th-228/Pb-212 generator platform, Pb-212 can be reliably supplied for research and clinical use. The technology underpins several ongoing clinical trials evaluating innovative cancer treatment approaches.

Please note that your order date is important due to production, calibration and shipment days.